Manulife stock joins UBS in Japan private-equity programme

Manulife Investment Management and UBS's Unified Global Alternatives business announced on Tuesday, November 10, 2026, a collaboration on a customized Japan private-equity co-investment programme for wealth-management clients. The announcement was carried by AAP, which reproduced the companies' release.

Manulife broadens private markets reach

The programme combines Manulife Investment Management's regional private-equity experience, sponsor relationships and underwriting capabilities with UBS's alternatives expertise, global scale and distribution network. The stated aim is to give wealth-management clients customized access to co-investment opportunities in Japan.

Fabio Fontainha, Manulife's chief executive officer for Wealth & Asset Management in Asia, described the collaboration as part of the company's effort to develop private-market solutions and use strategic partnerships to extend its global investment capabilities. Vipon Ghai, Manulife Investment Management's global head of private equity, said the partners seek to provide investors with access to Japanese opportunities.

Japan deal flow is central thesis

Liam Coppinger, head of private equity Asia at Manulife Investment Management, pointed to longstanding sponsor relationships and disciplined underwriting as the foundation for identifying opportunities and building diversified portfolios. UBS's Qingkun Guo said Japan could be entering a more favorable buyout environment, citing business successions, corporate carve-outs and take-private transactions as potential sources of deal flow.

UBS said its Unified Global Alternatives business had combined invested assets of 371 billion US dollars as of September 30, 2026. That figure describes the wider alternatives platform rather than the size of the new Japan programme. The announcement did not specify a programme size, investment timetable, fees or the first portfolio companies, leaving the near-term contribution to Manulife's earnings undefined.

Stock context remains measured

Manulife stock traded at 40.16 euros on Lang & Schwarz at 13:19 CET on Thursday, November 12, 2026. The partnership broadens Manulife's potential private-markets offering, but its immediate financial significance will depend on the programme's eventual scale, terms and investment activity.

Broader Canadian equity sentiment can be tracked through the S&P/TSX Composite.

More news and analyses on Manulife stock.